SPRUCE BIOSCIENCES INC (SPRB)
US85209E1091 - Common Stock
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Gap analysis on 2024-12-11: gap up and gap down stocks in today's session.
Top movers in Wednesday's pre-market session
Top movers in Wednesday's pre-market session
Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder
On Tuesday, Spruce Biosciences, Inc. (NASDAQ:SPRB) revealed topline results from its CAHmelia-204 study of tildacerfont in adult CAH and its CAHptain-205 study of tildacerfont in adult and pediatric CAH. Congenital adrenal hyperplasia (CAH) is a genetic disease that affects the adrenal glands and prevents the production of hormones like cortisol, aldosterone, and androgens. Also Read: Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disord
Which stocks are moving after the closing bell on Tuesday?
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spruce Biosciences (NASDAQ:SPRB) just reported results for the second quarter o...
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
Spruce Biosciences Recognized as a Bay Area Best Place to Work
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spruce Biosciences (NASDAQ:SPRB) just reported results for the first quarter of...
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Spruce Biosciences to Participate in May Investor Conferences
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or the "Company") (NASDAQ: SPRB). Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or the "Company") (NASDAQ: SPRB). Such...
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or the "Company") (NASDAQ: SPRB). Such...
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
Anheuser-Busch stock is falling on Thursday following news that 10% holder Altria is selling a portion of its stake in BUD shares.
Why Is Fisker (FSR) Stock Down 41% Today?
Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy.
Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported.